{
"id":"mk19_a_nr_s3",
"subspecialtyId":"nr",
"title":"Seizures and Epilepsy",
"jsonContent":{
"type":"section",
"id":"mk19_a_nr_s3",
"title":{
"__html":"Seizures and Epilepsy"
},
"titleNode":{
"type":"section-title",
"hlId":"e24d1b",
"children":[
"Seizures and Epilepsy"
]
},
"children":[
{
"type":"section",
"id":"mk19_a_nr_s3_1",
"title":{
"__html":"Clinical Presentation of Seizures"
},
"titleNode":{
"type":"section-title",
"hlId":"55ba55",
"children":[
"Clinical Presentation of Seizures"
]
},
"children":[
{
"type":"p",
"hlId":"f7cc4e",
"children":[
"Epilepsy is defined as at least two unprovoked seizures more than 24 hours apart, or one unprovoked seizure with a risk of further seizures that is similar to the risk after two unprovoked seizures (at least 60%). The term “epileptic seizure” does not imply that the seizure is related to epilepsy; rather, it means that the seizure is secondary to abnormal electrical activity in the brain and not to some other cause (such as syncope or psychiatric disease). The diagnosis of epilepsy relies on a detailed patient history. Seizures are characteristically stereotyped; symptom variability from event to event suggests an alternative diagnosis. Epilepsy usually requires antiepileptic drug (AED) therapy, but isolated seizures may not, especially if provoked by reversible or preventable causes. The terminology of seizure classification is evolving but is usually divided into focal and generalized categories ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"figure-link",
"target":"mk19_a_nr_f05",
"wrapId":"1",
"children":[
"Figure 5"
]
}
]
},
")"
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"mk19_a_nr_f05"
]
},
{
"type":"section",
"id":"mk19_a_nr_s3_1_1",
"title":{
"__html":"Focal Seizures"
},
"titleNode":{
"type":"section-title",
"hlId":"ee4d8a",
"children":[
"Focal Seizures"
]
},
"children":[
{
"type":"p",
"hlId":"53adc7",
"children":[
"Focal seizures may be classified as “aware” or “impaired awareness” (formerly, simple partial and complex partial, respectively). The first type includes auras, which are very localized focal seizures with varying manifestations depending on the site of origin within the brain ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t14",
"wrapId":"2",
"children":[
"Table 14"
]
}
]
},
")"
]
},
". Seizures involving impaired awareness may affect memory, responsiveness, language, or cognition. Both focal seizures and generalized absence seizures can present as “staring episodes” and must be carefully differentiated ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t15",
"wrapId":"2",
"children":[
"Table 15"
]
}
]
},
")"
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"2",
"contentIds":[
"mk19_a_nr_t14",
"mk19_a_nr_t15"
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s3_1_2",
"title":{
"__html":"Generalized Seizures"
},
"titleNode":{
"type":"section-title",
"hlId":"df6532",
"children":[
"Generalized Seizures"
]
},
"children":[
{
"type":"p",
"hlId":"8a2cab",
"children":[
"Generalized tonic-clonic seizures (GTCS) have a characteristic tonic phase of whole-body stiffening with eyes wide open and a single loud groan (or “ictal cry”), followed by a clonic phase of rhythmic synchronous limb jerking that is initially fast and gradually slows and ceases. The seizure typically lasts 1 to 3 minutes and is often followed by stertor (deep, slow snoring). A postictal state with confusion, hypersomnolence, and fatigue is common and can persist for hours or even days."
]
},
{
"type":"p",
"hlId":"b19686",
"children":[
"GTCS may be preceded by other seizure types, either generalized or focal. Aura or automatisms before GTCS and postevent unilateral weakness (Todd paralysis) suggest focal onset."
]
},
{
"type":"p",
"hlId":"ecc9c8",
"children":[
"Absence seizures are characterized by brief episodes of staring (see ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t15",
"wrapId":"3",
"children":[
"Table 15"
]
}
]
},
")"
]
},
". They may occur as the only seizure type in school-age children and are often confused with attention- deficit/hyperactivity disorder."
]
},
{
"type":"inline-wrap",
"wrapId":"3",
"contentIds":[
"mk19_a_nr_t15"
]
},
{
"type":"p",
"hlId":"8e9fd6",
"children":[
"Myoclonus is a single quick jerk of a limb or the entire body lasting less than a second and is not always associated with a seizure (see ",
{
"type":"cross-reference",
"target":"mk19_a_nr_s6_3_4",
"children":[
"Movement Disorders"
]
},
"). A diagnosis of myoclonic seizures can be confirmed by electroencephalography (EEG), with each jerk associated with a generalized spike-and-wave discharge ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"figure-link",
"target":"mk19_a_nr_f06",
"wrapId":"4",
"children":[
"Figure 6"
]
}
]
},
")"
]
},
". Myoclonic seizures also can occur repetitively and result in falls. Awareness is maintained and duration is very short (<1 second), which differentiates myoclonic seizures from GTCS."
]
},
{
"type":"inline-wrap",
"wrapId":"4",
"contentIds":[
"mk19_a_nr_f06"
]
},
{
"type":"p",
"hlId":"21dce6",
"children":[
"Tonic seizures present as episodes of increased muscle tone, ranging from mild extension of the arms and head to a more severe stiffening of the entire body. Atonic seizures present with sudden loss of muscle tone. Both tonic and atonic seizures occur with no warning, last a few seconds, and cause altered awareness, which often leads to falls and physical injuries; they lack postevent confusion. Prolonged episodes of increased or decreased tone with long duration of loss of consciousness are unlikely to represent seizures."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"7a3cf0",
"children":[
"Epilepsy is defined as at least two unprovoked seizures more than 24 hours apart or one unprovoked seizure with a risk of further seizures that is similar to the risk after two unprovoked seizures (at least 60%)."
]
},
{
"type":"keypoint",
"hlId":"568e3c",
"children":[
"Although both may present as staring spells, focal seizures with impaired awareness can be distinguished from absence seizures by longer duration, lower frequency, and the presence of aura and postictal confusion."
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s3_2",
"title":{
"__html":"Epilepsy Syndromes"
},
"titleNode":{
"type":"section-title",
"hlId":"88ad37",
"children":[
"Epilepsy Syndromes"
]
},
"children":[
{
"type":"section",
"id":"mk19_a_nr_s3_2_1",
"title":{
"__html":"Focal Epilepsies"
},
"titleNode":{
"type":"section-title",
"hlId":"a43e65",
"children":[
"Focal Epilepsies"
]
},
"children":[
{
"type":"p",
"hlId":"4f9332",
"children":[
"Identifiable causes of focal epilepsies include structural lesions that may be seen on MRI, such as mesial temporal sclerosis with hippocampal atrophy ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"figure-link",
"target":"mk19_a_nr_f07",
"wrapId":"5",
"children":[
"Figure 7"
]
}
]
},
")"
]
},
", cavernous malformations, cortical dysplasia ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"figure-link",
"target":"mk19_a_nr_f08",
"wrapId":"5",
"children":[
"Figure 8"
]
}
]
},
")"
]
},
", traumatic brain injury, stroke, and tumors. EEG may show focal spikes or sharp waves in the appropriate brain region ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"figure-link",
"target":"mk19_a_nr_f09",
"wrapId":"5",
"children":[
"Figure 9"
]
}
]
},
")"
]
},
". In most adults with focal epilepsy, however, brain MRI is normal and the cause is unknown."
]
},
{
"type":"inline-wrap",
"wrapId":"5",
"contentIds":[
"mk19_a_nr_f07",
"mk19_a_nr_f08",
"mk19_a_nr_f09"
]
},
{
"type":"p",
"hlId":"883bb9",
"children":[
"Temporal lobe epilepsy is the most common adult-onset focal epilepsy. Typical symptoms of a temporal lobe focal seizure include aura of déjà vu, fear, or a rising sensation in the stomach; loss of awareness; staring; behavior arrest; and amnesia. Semipurposeful repetitive mouth or ipsilateral hand movements, called automatisms, may be observed. Speech arrest may be seen with involvement of the dominant hemisphere."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"ed32e9",
"children":[
"Mesial temporal sclerosis with hippocampal atrophy is commonly associated with temporal lobe epilepsy."
]
},
{
"type":"keypoint",
"hlId":"9c29d5",
"children":[
"Temporal lobe epilepsy is the most common adult-onset focal epilepsy; typical symptoms include aura, loss of awareness, staring, behavior arrest, and amnesia."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s3_2_2",
"title":{
"__html":"Idiopathic (Genetic) Generalized Epilepsies"
},
"titleNode":{
"type":"section-title",
"hlId":"5f9a43",
"children":[
"Idiopathic (Genetic) Generalized Epilepsies"
]
},
"children":[
{
"type":"p",
"hlId":"d5b3c3",
"children":[
"Idiopathic epilepsies are “pure” without an underlying neurologic disorder, often having complex, polygenic inheritance (thus, often no family history or identifiable single genetic mutation). In adults, juvenile myoclonic epilepsy (JME) is the most common form of idiopathic/genetic generalized epilepsy. Seizures in JME are often called “college seizures” because of the age of onset (teens or twenties) and associated triggers (sleep deprivation, alcohol use, and stress). Epilepsy may not be diagnosed until the first GTCS occurs because myoclonic seizures often remain unrecognized until a physician takes a careful and complete history."
]
},
{
"type":"p",
"hlId":"25245b",
"children":[
"The presence of myoclonic seizures is required for the diagnosis of JME; patients may report dropping items from their hands, often a coffee cup or hairbrush, because myoclonic seizures in JME generally occur in the morning. Most affected patients have GTCS, and approximately 30% of patients have absence seizures. Patients are usually otherwise neurologically healthy and can live relatively normal lives because seizures are often controlled with one or two AEDs. Brain MRI is typically normal, and EEG may show generalized spike-and-wave discharges (see ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"figure-link",
"target":"mk19_a_nr_f06",
"wrapId":"6",
"children":[
"Figure 6"
]
}
]
},
")"
]
},
". Lifelong AED therapy is typically required."
]
},
{
"type":"inline-wrap",
"wrapId":"6",
"contentIds":[
"mk19_a_nr_f06"
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"0ef7e1",
"children":[
"The presence of myoclonic seizures is required for the diagnosis of juvenile myoclonic epilepsy (JME); JME often is not diagnosed, however, until the first generalized tonic-clonic seizure occurs because myoclonic seizures often remain unrecognized."
]
},
{
"type":"keypoint",
"hlId":"a832db",
"children":[
"Lifelong antiepileptic drug therapy is typically required for patients with juvenile myoclonic epilepsy."
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s3_3",
"title":{
"__html":"Diagnostic Evaluation of Seizures and Epilepsy"
},
"titleNode":{
"type":"section-title",
"hlId":"4d1b36",
"children":[
"Diagnostic Evaluation of Seizures and Epilepsy"
]
},
"children":[
{
"type":"section",
"id":"mk19_a_nr_s3_3_1",
"title":{
"__html":"Initial Approach to the Patient with a First Seizure"
},
"titleNode":{
"type":"section-title",
"hlId":"ac051f",
"children":[
"Initial Approach to the Patient with a First Seizure"
]
},
"children":[
{
"type":"p",
"hlId":"5d129e",
"children":[
"For any patient with a first seizure, obtaining a detailed history is crucial to distinguish seizures from other causes of symptoms. The distinction between seizures and nonepileptic events and clarification of first-time versus recurrent episodes are key. A history of previous staring events or myoclonus may help identify patients with epilepsy and should be specifically sought through careful questioning."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"db731e",
"children":[
"A history of previous staring events or myoclonus may help identify patients with epilepsy."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s3_3_2",
"title":{
"__html":"Differential Diagnosis of Seizures"
},
"titleNode":{
"type":"section-title",
"hlId":"a087f5",
"children":[
"Differential Diagnosis of Seizures"
]
},
"children":[
{
"type":"p",
"hlId":"9c9a42",
"children":[
"Many episodic disorders mimic seizures but are nonepileptic events. These include syncope, migraine, movement disorders (tremor, tics), sleep disorders, stroke, and psychogenic events. Seizures usually have positive symptoms, such as jerking, tingling, and visual flashes, whereas strokes have negative symptoms, such as weakness, numbness, and loss of vision. Normal mentation with a headache after the episode suggests migraine. Occurrence only in public suggests panic disorder with agoraphobia."
]
},
{
"type":"p",
"hlId":"392b31",
"children":[
"Associated lightheadedness or chest pain may suggest syncope or cardiac disease. Syncope often presents with shaking (“convulsive syncope”) and must be differentiated from GTCS ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t16",
"wrapId":"7",
"children":[
"Table 16"
]
}
]
},
")"
]
},
". In one study, more than 90% of healthy volunteers had nonepileptic myoclonus (generalized or multifocal) when syncope was induced; only a minority had classic, motionless syncope. For distinguishing seizures from syncope and psychogenic loss of consciousness, video EEG can be very useful, in combination with tilt-table testing, because it can specifically differentiate these events."
]
},
{
"type":"inline-wrap",
"wrapId":"7",
"contentIds":[
"mk19_a_nr_t16"
]
},
{
"type":"section",
"id":"mk19_a_nr_s3_3_2_1",
"title":{
"__html":"Psychogenic Nonepileptic Spells/Events"
},
"titleNode":{
"type":"section-title",
"hlId":"c67702",
"children":[
"Psychogenic Nonepileptic Spells/Events"
]
},
"children":[
{
"type":"p",
"hlId":"a2c0ec",
"children":[
"Psychogenic nonepileptic spells/events (PNES) were formerly called pseudoseizures or psychogenic nonepileptic seizures. These latter terms should be avoided because “pseudo” implies falseness and “seizure” is a misnomer. PNES are most often related to posttraumatic stress disorder or conversion disorder. Factitious disorder and malingering are rare and far less likely. Patients with PNES often have a history of military combat, sexual or physical abuse, chronic medical illness, or prominent life stressors. PNES often mimic GTCS, but certain features help distinguish the diagnoses ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t17",
"wrapId":"8",
"children":[
"Table 17"
]
}
]
},
")"
]
},
". Event capture during video EEG monitoring usually is required to confirm the diagnosis. PNES are commonly associated with treatment failure; management should emphasize early video EEG monitoring over polypharmacy."
]
},
{
"type":"inline-wrap",
"wrapId":"8",
"contentIds":[
"mk19_a_nr_t17"
]
},
{
"type":"p",
"hlId":"cdc381",
"children":[
"Returning combat veterans who develop seizures require careful evaluation, often including video EEG monitoring. Many have had head trauma and are at increased risk for epilepsy, but many also have posttraumatic stress disorder and may have PNES. Assuming a diagnosis of epilepsy and empirically treating the patient can be detrimental, especially because veterans tend to have a delay in the diagnosis of PNES compared with the general population."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"f20216",
"children":[
"Syncope often presents with shaking (“convulsive syncope”); video electroencephalography with tilt table testing can be useful to differentiate syncope from seizures and nonepileptic events."
]
},
{
"type":"keypoint",
"hlId":"ac9c3e",
"children":[
"Psychogenic nonepileptic spells/events are most often related to posttraumatic stress disorder or conversion disorder, and factitious disorder and malingering are rare; management should emphasize early video EEG monitoring over polypharmacy."
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s3_3_3",
"title":{
"__html":"Diagnostic Evaluation"
},
"titleNode":{
"type":"section-title",
"hlId":"08b6da",
"children":[
"Diagnostic Evaluation"
]
},
"children":[
{
"type":"p",
"hlId":"59682c",
"children":[
"Neuroimaging is recommended for all patients with a first seizure. CT of the head is adequate initially to rapidly exclude emergent pathology, including hemorrhage, but MRI is recommended in most patients. The use of contrast may be deferred unless infection, tumor, or vascular lesions are suspected. Because temporal lobe epilepsy is common, MRI sequences focusing on the hippocampus and temporal lobes are useful (coronal T2-weighted imaging, fluid-attenuated inversion recovery imaging, and thin-slice T1-weighted imaging)."
]
},
{
"type":"p",
"hlId":"9c15cc",
"children":[
"Outpatient EEG also is recommended in patients with a first seizure. Because capture of an actual seizure is unlikely, the physician must rely on “epileptiform” abnormalities, such as focal sharp waves (see ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"figure-link",
"target":"mk19_a_nr_f09",
"wrapId":"9",
"children":[
"Figure 9"
]
}
]
},
")"
]
},
" or generalized spike-and-wave discharges (see ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"figure-link",
"target":"mk19_a_nr_f06",
"wrapId":"9",
"children":[
"Figure 6"
]
}
]
},
")"
]
},
". These findings are not diagnostically confirmatory; rather, they may help support the diagnosis in an appropriate clinical context. A single routine EEG is only 40% to 50% sensitive for such findings, so clinical judgment based on history remains critical. Emergent lumbar puncture is recommended in adults only if an infectious cause, such as meningitis or encephalitis, is suspected."
]
},
{
"type":"inline-wrap",
"wrapId":"9",
"contentIds":[
"mk19_a_nr_f09",
"mk19_a_nr_f06"
]
},
{
"type":"section",
"id":"mk19_a_nr_s3_3_3_1",
"title":{
"__html":"Epilepsy Monitoring Units"
},
"titleNode":{
"type":"section-title",
"hlId":"9e67b9",
"children":[
"Epilepsy Monitoring Units"
]
},
"children":[
{
"type":"p",
"hlId":"cd76b9",
"children":[
"A normal EEG does not rule out epilepsy. Capturing events during continuous video EEG monitoring is the gold standard in diagnosis, typically performed in a multiple-day epilepsy unit hospitalization in parallel with AED withdrawal under close supervision. Patients who have not responded to two adequately dosed AEDs are considered to have refractory disease (see ",
{
"type":"cross-reference",
"target":"mk19_a_nr_s3_5_2",
"children":[
"Drug-Resistant Epilepsy and Epilepsy Surgery"
]
},
"); they should be referred to an epilepsy center, where such an evaluation can both confirm the diagnosis of epilepsy and determine candidacy for epilepsy surgery."
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s3_3_3_2",
"title":{
"__html":"Other Continuous Electroencephalographic Monitoring"
},
"titleNode":{
"type":"section-title",
"hlId":"580840",
"children":[
"Other Continuous Electroencephalographic Monitoring"
]
},
"children":[
{
"type":"p",
"hlId":"44ae42",
"children":[
"Continuous video EEG monitoring also is useful in the ICU ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t18",
"wrapId":"10",
"children":[
"Table 18"
]
}
]
},
")"
]
},
". It can determine if episodic events are truly seizures, particularly in sedated or confused patients who cannot provide a history. This type of EEG is often the only method of diagnosing nonconvulsive status epilepticus (see later discussion)."
]
},
{
"type":"inline-wrap",
"wrapId":"10",
"contentIds":[
"mk19_a_nr_t18"
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"d819bb",
"hvc":true,
"children":[
"MRI and electroencephalography are recommended for all patients with a first seizure; lumbar puncture is recommended only if an infectious cause is suspected."
]
},
{
"type":"keypoint",
"hlId":"d7f70b",
"children":[
"A single routine electroencephalographic study is only 40% to 50% sensitive in diagnosing epilepsy."
]
},
{
"type":"keypoint",
"hlId":"356f2a",
"children":[
"Continuous video electroencephalography is the only method of diagnosing nonconvulsive status epilepticus, but diagnosis often requires clinical correlation as confirmation."
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s3_3_4",
"title":{
"__html":"Provoked, Unprovoked, and Triggered Seizures"
},
"titleNode":{
"type":"section-title",
"hlId":"00176b",
"children":[
"Provoked, Unprovoked, and Triggered Seizures"
]
},
"children":[
{
"type":"p",
"hlId":"b53dbc",
"children":[
"Provoking factors, risk factors, and triggers all can lead to seizures ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t19",
"wrapId":"11",
"children":[
"Table 19"
]
}
]
},
")"
]
},
", and differentiating among them is essential. Provoking factors can cause seizures in patients with or without epilepsy; avoidance of these provocations should prevent further seizures. Attention should be paid to the patient's medications, and drugs that can cause a seizure or lower seizure threshold (such as tramadol, meperidine, bupropion, fluoroquinolones, carbapenems, and cefepime) should be avoided. Risk factors increasing the chance of developing epilepsy include a history of brain trauma, meningitis, or stroke, but an acute symptomatic seizure (occurring within the first week afterward) may not necessarily lead to the development of epilepsy. Triggers lead to seizures in patients with pre-existing epilepsy but do not cause epilepsy."
]
},
{
"type":"inline-wrap",
"wrapId":"11",
"contentIds":[
"mk19_a_nr_t19"
]
},
{
"type":"p",
"hlId":"d75833",
"children":[
"Determining the risk of recurrence guides the decision to treat. The 2-year recurrence risk after a single unprovoked seizure is approximately 40%. Risk is lower (20%-30%) if there are no epilepsy risk factors and the MRI and EEG are normal. A first unprovoked seizure is often not treated; although treatment may reduce the risk of seizure over the next 2 years, it does not change a patient's long-term prognosis for developing epilepsy. Treatment is recommended in the setting of two unprovoked seizures (or one unprovoked seizure with significant EEG or MRI abnormalities, such as trauma or stroke) because recurrence risk is at least 60%."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"bddad2",
"hvc":true,
"children":[
"After a single unprovoked seizure with no abnormalities on MRI or electroencephalography and with no risk factors for epilepsy, the 2-year recurrence risk is approximately 20% to 30%, and treatment is typically withheld."
]
},
{
"type":"keypoint",
"hlId":"853d89",
"children":[
"In the setting of two unprovoked seizures or one unprovoked seizure with significant electroencephalographic or MRI abnormalities, the recurrence risk is at least 60%, and treatment is recommended."
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s3_4",
"title":{
"__html":"Treatment of Epilepsy"
},
"titleNode":{
"type":"section-title",
"hlId":"a053bf",
"children":[
"Treatment of Epilepsy"
]
},
"children":[
{
"type":"section",
"id":"mk19_a_nr_s3_4_1",
"title":{
"__html":"Antiepileptic Drug Therapy"
},
"titleNode":{
"type":"section-title",
"hlId":"79b3c7",
"children":[
"Antiepileptic Drug Therapy"
]
},
"children":[
{
"type":"p",
"hlId":"da1ab5",
"children":[
"Empiric pharmacologic treatment generally is not recommended unless the patient's history is strongly suggestive of seizures or epilepsy. The exception is convulsive status epilepticus, which must be treated emergently if clinically suspected. Similarly, prophylactic treatment is avoided except in specific situations, such as during the week after severe head trauma or brain tumor resection. Alcohol- or benzodiazepine-withdrawal seizures typically are not treated with AEDs."
]
},
{
"type":"section",
"id":"mk19_a_nr_s3_4_1_1",
"title":{
"__html":"Selection and Adverse Effects of Antiepileptic Drugs"
},
"titleNode":{
"type":"section-title",
"hlId":"8d822a",
"children":[
"Selection and Adverse Effects of Antiepileptic Drugs"
]
},
"children":[
{
"type":"p",
"hlId":"b227b1",
"children":[
"Many AEDs are available for patients with epilepsy ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t20",
"wrapId":"12",
"children":[
"Table 20"
]
}
]
},
")"
]
},
". Older AEDs, such as phenobarbital, phenytoin, carbamazepine, and valproate, are typically not preferred; although newer AEDs are not more effective in controlling seizures, they typically have fewer adverse effects, fewer drug interactions, and a reduced need for laboratory monitoring, although cost may be higher. Most often, treatment is guided by the seizure type rather than AED mechanism or epilepsy cause."
]
},
{
"type":"inline-wrap",
"wrapId":"12",
"contentIds":[
"mk19_a_nr_t20"
]
},
{
"type":"p",
"hlId":"728a07",
"children":[
"Common adverse effects and monitoring recommendations are listed in ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t21",
"wrapId":"13",
"children":[
"Table 21"
]
}
]
},
". Key dose-dependent adverse effects include oxcarbazepine-related hyponatremia and valproate–related thrombocytopenia. Hyponatremia is a major concern with use of oxcarbazepine, carbamazepine, or eslicarbazepine in older patients, especially in those with concomitant diuretic use."
]
},
{
"type":"inline-wrap",
"wrapId":"13",
"contentIds":[
"mk19_a_nr_t21"
]
},
{
"type":"p",
"hlId":"6eb8b4",
"children":[
"Enzyme-inducing AEDs ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t22",
"wrapId":"14",
"children":[
"Table 22"
]
}
]
},
")"
]
},
" increase statin clearance and necessitate higher doses or alternative options; they also can increase bone catabolism. Therefore, bone density testing and supplementation of calcium and vitamin D are recommended with chronic use of valproic acid or enzyme-inducing AEDs. This precautionary step is recommended even in patients without traditional osteoporosis risk factors."
]
},
{
"type":"inline-wrap",
"wrapId":"14",
"contentIds":[
"mk19_a_nr_t22"
]
},
{
"type":"p",
"hlId":"b8c0a2",
"children":[
"Phenytoin, carbamazepine, phenobarbital, and lamotrigine are AEDs that commonly cause rash, which usually resolves with discontinuation of the drug but sometimes may be severe and life-threatening. For example, rapid titration of lamotrigine has been associated with the development of Stevens-Johnson syndrome, toxic epidermal necrolysis, drug-induced hypersensitivity syndrome, and hemophagocytic lymphohistiocytosis. Gabapentin has a low incidence of rash and also has good evidence of efficacy in epilepsy in older adults."
]
},
{
"type":"p",
"hlId":"587fe4",
"children":[
"Nevertheless, expert consensus considers lamotrigine to be a first-line, broad spectrum AED with an overall excellent safety and efficacy profile, when titrated slowly."
]
},
{
"type":"p",
"hlId":"4d714b",
"children":[
"All AEDs carry a warning about worsening depression and suicidality, and all patients must be screened and monitored for these symptoms. Levetiracetam may cause depression, anxiety, anger, or agitation. Perampanel may cause homicidal ideation. Topiramate may cause psychosis. Lamotrigine and valproic acid, on the other hand, are mood stabilizers."
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s3_4_1_2",
"title":{
"__html":"Monitoring and Discontinuing Antiepileptic Drugs"
},
"titleNode":{
"type":"section-title",
"hlId":"19d763",
"children":[
"Monitoring and Discontinuing Antiepileptic Drugs"
]
},
"children":[
{
"type":"p",
"hlId":"23c292",
"children":[
"Measuring serum levels of certain AEDs (phenytoin, carbamazepine, valproic acid, phenobarbital, oxcarbazepine, lamotrigine) is useful, given their known therapeutic windows and predictable dose-related adverse effects. However, in a patient whose epilepsy is well controlled without clinical adverse effects, dose reduction because of high levels usually is not warranted."
]
},
{
"type":"p",
"hlId":"960a0c",
"children":[
"Generic AEDs are appropriate for most patients, given recent guidelines. Well-designed studies have not shown differences in AED bioequivalence (according to FDA standards) when switching between generic drugs or switching from a brand to a generic drug. Monitoring for AED toxicity and seizures is advised if any change is made."
]
},
{
"type":"p",
"hlId":"e36d91",
"children":[
"In adults who are seizure-free for at least 2 years, the American Academy of Neurology recommends discussing the risks and benefits of AED withdrawal with the patient. Risks include the possibility of higher seizure recurrence and, if seizures recur, a small chance that they will no longer respond to medications. Shared decision making on AED withdrawal also should explore the quality of life of individual patients. The best predictor of seizure freedom is time; a prolonged period of seizure freedom predicts further seizure freedom. Factors prohibiting AED weaning include the presence of JME, a history of difficulties in early seizure control, and the presence of significant epilepsy risk factors (see ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t19",
"wrapId":"15",
"children":[
"Table 19"
]
}
]
},
")"
]
},
". It is unknown if EEG or imaging studies helpfully inform the decision to withdraw AEDs. There are no standardized AED tapering schedules."
]
},
{
"type":"inline-wrap",
"wrapId":"15",
"contentIds":[
"mk19_a_nr_t19"
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"6ebbd4",
"children":[
"Newer antiepileptic drugs (AEDs), although not more effective in controlling seizures than older AEDs, are often preferred because they have fewer adverse effects, fewer drug interactions, and a reduced need for laboratory monitoring."
]
},
{
"type":"keypoint",
"hlId":"38348b",
"children":[
"Epilepsy treatment usually is guided by the seizure type rather than drug mechanism or epilepsy cause."
]
},
{
"type":"keypoint",
"hlId":"7cf7f8",
"children":[
"Enzyme-inducing antiepileptic drugs (AEDs) increase statin clearance and necessitate higher doses or alternative options; because these AEDs and valproic acid also can increase bone catabolism, bone density testing and supplemental calcium and vitamin D are recommended with chronic use."
]
},
{
"type":"keypoint",
"hlId":"29f6b5",
"children":[
"In adults who are seizure-free for at least 2 years, the American Academy of Neurology recommends discussing the risks and benefits of antiepileptic drug withdrawal with the patient; risks include the possibility of higher seizure recurrence and, if seizures recur, a small chance that they will no longer respond to medications."
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s3_4_2",
"title":{
"__html":"Counseling and Lifestyle Adjustments"
},
"titleNode":{
"type":"section-title",
"hlId":"4e3392",
"children":[
"Counseling and Lifestyle Adjustments"
]
},
"children":[
{
"type":"p",
"hlId":"6f27d0",
"children":[
"All patients experiencing a seizure, even a single provoked seizure, must be instructed about seizure precautions, including driving restrictions. Most states restrict driving in patients with any episode of altered awareness or motor control, with the restriction varying by state from 3 to 12 months (see ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.epilepsy.com/driving-laws",
"target":"_blank"
},
"children":[
"www.epilepsy.com/driving-laws"
]
},
"). Additionally, patients should avoid common triggers and provoking factors (see ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t19",
"wrapId":"16",
"children":[
"Table 19"
]
}
]
},
")"
]
},
". Most patients with epilepsy can work, even if they are not completely seizure-free. Patients should avoid operating heavy machinery, using firearms, lifting more than 9 kg (20 lb), taking tub baths, swimming in unsupervised locations, and being near open flames or heights (such as rooftops)."
]
},
{
"type":"inline-wrap",
"wrapId":"16",
"contentIds":[
"mk19_a_nr_t19"
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s3_5",
"title":{
"__html":"Comorbidities and Complications of Epilepsy"
},
"titleNode":{
"type":"section-title",
"hlId":"cdd576",
"children":[
"Comorbidities and Complications of Epilepsy"
]
},
"children":[
{
"type":"section",
"id":"mk19_a_nr_s3_5_1",
"title":{
"__html":"Sudden Unexpected Death in Epilepsy Patients"
},
"titleNode":{
"type":"section-title",
"hlId":"86fc88",
"children":[
"Sudden Unexpected Death in Epilepsy Patients"
]
},
"children":[
{
"type":"p",
"hlId":"ee3468",
"children":[
"Besides the risk of trauma, asphyxia, and death from a seizure or status epilepticus, epilepsy patients are at risk for unexpected death. This risk is approximately 1 in 1000 and increases to approximately 1 in 100 in patients with drug-resistant seizures, especially those with uncontrolled GTCS and those taking multiple AEDs. Mechanisms are unknown and may involve cardiac, respiratory, and autonomic dysregulation. Studies show that patients prefer to discuss sudden unexpected death in epilepsy openly; doing so can encourage medication adherence and home safety planning (such as using webcams and bed monitors and sharing of bedrooms)."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"6b5f04",
"children":[
"The risk of sudden unexpected death in epilepsy is approximately 1 in 1000 and increases to approximately 1 in 100 in patients with drug-resistant seizures, especially those with uncontrolled generalized tonic-clonic seizures and those taking multiple antiepileptic drugs."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s3_5_2",
"title":{
"__html":"Drug-Resistant Epilepsy and Epilepsy Surgery"
},
"titleNode":{
"type":"section-title",
"hlId":"977298",
"children":[
"Drug-Resistant Epilepsy and Epilepsy Surgery"
]
},
"children":[
{
"type":"p",
"hlId":"ba00d8",
"children":[
"Any patient who does not achieve seizure freedom after treatment with two adequately dosed, appropriately chosen AEDs is considered to have drug-resistant epilepsy. Referral to an epilepsy center is indicated both to confirm the diagnosis and to evaluate the patient for surgical candidacy, starting with video EEG monitoring. Because the chance of achieving seizure control from additional medications (a regimen of three or more AEDs) is less than 10%, other treatment options must be considered. In appropriately chosen surgical candidates, especially those with temporal lobe epilepsy due to mesial temporal sclerosis, resection can lead to seizure freedom in 60% to 70% of patients. Implantable vagus nerve stimulators and the ketogenic diet are available palliative therapies but do not result in complete seizure control."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"5b7286",
"children":[
"Any patient who does not achieve seizure freedom after treatment with two adequately dosed, appropriately chosen antiepileptic drugs is considered to have drug-resistant epilepsy and should be referred to an epilepsy center to both confirm the diagnosis and evaluate the patient for surgical candidacy."
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s3_6",
"title":{
"__html":"Seizures and Epilepsy in Specific Populations"
},
"titleNode":{
"type":"section-title",
"hlId":"bdef07",
"children":[
"Seizures and Epilepsy in Specific Populations"
]
},
"children":[
{
"type":"section",
"id":"mk19_a_nr_s3_6_1",
"title":{
"__html":"Older Adults"
},
"titleNode":{
"type":"section-title",
"hlId":"075126",
"children":[
"Older Adults"
]
},
"children":[
{
"type":"p",
"hlId":"884e64",
"children":[
"Incidence of new-onset epilepsy is highest in older adults (age >60 years). Because recurrence after a new-onset seizure in this age group is more likely (50% to 60%) than in younger adults (40%), treatment after one seizure is sometimes considered. Major risk factors for seizure recurrence include stroke and dementia. Older adults usually require lower AED doses and are at increased risk of drug interactions and decreased drug clearance. Data suggest that levetiracetam, lamotrigine, and gabapentin are better tolerated and no less effective when compared with older AEDs (see ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t20",
"wrapId":"17",
"children":[
"Table 20"
]
}
]
},
")"
]
},
". Valproic acid should be used with caution because it can cause (reversible) parkinsonism and cognitive dysfunction."
]
},
{
"type":"inline-wrap",
"wrapId":"17",
"contentIds":[
"mk19_a_nr_t20"
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"7a82d0",
"children":[
"In older patients, levetiracetam, lamotrigine, and gabapentin are better tolerated and no less effective when compared with older antiepileptic drugs."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s3_6_2",
"title":{
"__html":"Women with Epilepsy"
},
"titleNode":{
"type":"section-title",
"hlId":"bc4e7f",
"children":[
"Women with Epilepsy"
]
},
"children":[
{
"type":"p",
"hlId":"714bf9",
"children":[
"Women with epilepsy (WWE) may experience seizures around menstruation or ovulation. Some studies suggest adding progestin-containing oral contraceptives or acetazolamide to the AED regimen, but oophorectomy is not recommended to improve seizure control."
]
},
{
"type":"section",
"id":"mk19_a_nr_s3_6_2_1",
"title":{
"__html":"Reproductive Issues"
},
"titleNode":{
"type":"section-title",
"hlId":"107fcd",
"children":[
"Reproductive Issues"
]
},
"children":[
{
"type":"p",
"hlId":"81b2cf",
"children":[
"Evidence is contradictory about WWE having decreased fertility rates. Valproic acid, however, is associated with anovulation and polycystic ovary syndrome."
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s3_6_2_2",
"title":{
"__html":"Pregnancy and Nursing"
},
"titleNode":{
"type":"section-title",
"hlId":"55f3a7",
"children":[
"Pregnancy and Nursing"
]
},
"children":[
{
"type":"p",
"hlId":"a93394",
"children":[
"Most WWE have normal, healthy children. The rate of major congenital malformations (MCMs) in untreated WWE mirrors that of the general population. All WWE of childbearing potential should receive preconception counseling and folate supplementation. WWE who take AEDs are unlikely to have an increased risk of cesarean section, late-pregnancy bleeding, or premature delivery, unless they smoke; however, they may be at risk of having a small-for-gestational age child. The best predictor of seizure control during pregnancy is seizure frequency in the previous 9 to 12 months."
]
},
{
"type":"p",
"hlId":"152218",
"children":[
"Levetiracetam and lamotrigine are the preferred treatment options because of the lower risk of teratogenicity. Patients with difficult to control seizures, however, may need to continue teratogenic medications such as valproic acid. Discovery of pregnancy alone is not reason enough to stop or change AEDs if epilepsy is well controlled. Physicians must balance risk of teratogenicity with risk of uncontrolled seizures, particularly GTCS, which can result in fetal anoxia and death."
]
},
{
"type":"p",
"hlId":"f2f383",
"children":[
"Valproic acid, phenobarbital, and phenytoin are associated with MCMs and lower IQ in offspring; these drugs should be avoided if possible. Topiramate, carbamazepine, and AED polypharmacy also should also be avoided because of increased MCM risk. Valproic acid is associated with neural tube defects, and topiramate with cleft lip and palate. Topiramate is of special concern given its ability to induce metabolism of estrogen-containing contraceptive agents, leading to unexpected pregnancy with teratogenicity."
]
},
{
"type":"p",
"hlId":"532fa6",
"children":[
"Serum levels of lamotrigine, oxcarbazepine, and levetiracetam are known to decrease significantly during pregnancy. For lamotrigine, a dose escalation of approximately 50% is needed to maintain therapeutic levels and prevent seizures; levels should be followed at least monthly during pregnancy. Once delivery occurs, the lamotrigine dose should be rapidly decreased to avoid a sudden increase in serum levels and toxicity risk."
]
},
{
"type":"p",
"hlId":"ef8dad",
"children":[
"Breastfeeding is recommended in most women with epilepsy who take AEDs, as benefits generally outweigh risks. Infant sedation is a concern, but AED exposure through breast milk is probably less than that in utero."
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s3_6_2_3",
"title":{
"__html":"Contraception"
},
"titleNode":{
"type":"section-title",
"hlId":"5ed336",
"children":[
"Contraception"
]
},
"children":[
{
"type":"p",
"hlId":"93c671",
"children":[
"Enzyme-inducing AEDs (see ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t22",
"wrapId":"18",
"children":[
"Table 22"
]
}
]
},
")"
]
},
" increase oral contraceptive metabolism, which increases chances of pregnancy. Alternate methods of contraception, such as intrauterine devices or barrier methods, are recommended."
]
},
{
"type":"inline-wrap",
"wrapId":"18",
"contentIds":[
"mk19_a_nr_t22"
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"145865",
"children":[
"In women with epilepsy who are of child-bearing potential, levetiracetam and lamotrigine have minimal evidence of teratogenicity and are the preferred treatment options."
]
},
{
"type":"keypoint",
"hlId":"2ccbd0",
"children":[
"Discovery of pregnancy alone is not reason enough to stop antiepileptic drugs in women with epilepsy whose disease is well controlled; women with epilepsy must balance risk of teratogenicity with risk of uncontrolled seizures, particularly generalized tonic-clonic seizures, which can result in fetal anoxia and death."
]
},
{
"type":"keypoint",
"hlId":"64d6bc",
"children":[
"Valproic acid, phenobarbital, phenytoin, topiramate, carbamazepine, and antiepileptic drug polypharmacy are associated with major congenital malformations and, if possible, should be avoided in pregnant women with epilepsy."
]
}
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s3_7",
"title":{
"__html":"Status Epilepticus"
},
"titleNode":{
"type":"section-title",
"hlId":"fcf080",
"children":[
"Status Epilepticus"
]
},
"children":[
{
"type":"p",
"hlId":"fe4029",
"children":[
"Not all seizures require emergent treatment. Most GTCS will cease spontaneously within 2 to 3 minutes. Treatment also differs depending on the type of status epilepticus. Convulsive status epilepticus (CSE) is analogous to ventricular fibrillation (true emergency). Nonconvulsive status epilepticus (NCSE) is analogous to atrial fibrillation with or without rapid ventricular response (management varies with symptom severity). Seizure etiology most often determines outcome; thus, evaluation for serious causes (meningitis, intracranial hemorrhage) must in parallel with treatment. If meningitis is suspected, head CT is usually indicated before lumbar puncture, but no test should delay antibiotic administration."
]
},
{
"type":"section",
"id":"mk19_a_nr_s3_7_1",
"title":{
"__html":"Convulsive Status Epilepticus"
},
"titleNode":{
"type":"section-title",
"hlId":"d6a3ac",
"children":[
"Convulsive Status Epilepticus"
]
},
"children":[
{
"type":"p",
"hlId":"6aca81",
"children":[
"CSE is defined as a generalized tonic-clonic seizure lasting more than 5 minutes, or two within 5 minutes without return to baseline in between. CSE is diagnosed clinically and presents as continuous generalized clonic jerking of the entire body. Unless PNES is strongly suspected, empiric therapy is indicated without awaiting results of EEG, imaging, serum studies, or lumbar puncture because a longer duration of CSE is strongly linked to worse outcomes."
]
},
{
"type":"p",
"hlId":"b99e3a",
"children":[
"Securing the airway and obtaining intravenous (IV) access are the first steps in management ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"figure-link",
"target":"mk19_a_nr_f10",
"wrapId":"19",
"children":[
"Figure 10"
]
}
]
},
")"
]
},
". If point-of-care glucose testing is not available, thiamine should be given, followed by IV glucose. First-line treatment is an intravenous benzodiazepine. If IV access is not available, diazepam may be given rectally or intramuscularly, although absorption is erratic. Fear of respiratory depression should not limit treatment; there is clear evidence that intubation rates are lower when CSE is treated with benzodiazepines."
]
},
{
"type":"inline-wrap",
"wrapId":"19",
"contentIds":[
"mk19_a_nr_f10"
]
},
{
"type":"p",
"hlId":"3b8606",
"children":[
"Typically, benzodiazepines should be followed by an IV AED to avoid seizure recurrence. Fosphenytoin is preferred over phenytoin because it can be infused more rapidly and has a lower incidence of skin necrosis (due to drug extravasation). Both fosphenytoin and phenytoin can cause acute bradycardia and hypotension. Alternative second-line therapies include IV valproic acid or IV levetiracetam. There is insufficient evidence to support the use of lacosamide as a standard treatment in CSE."
]
},
{
"type":"p",
"hlId":"462750",
"children":[
"If convulsions stop, but the patient does not either improve within 10 minutes or return to baseline within 30 minutes, immediate continuous EEG is required to diagnose NCSE. NCSE after CSE is still a medical emergency and should be treated aggressively. If convulsive seizure activity does not cease, intubation is typically required, and patients are typically placed in an anesthetically induced coma for 24 to 48 hours using propofol, midazolam, or pentobarbital. IV anesthesia carries considerable risk, including prolonged ICU hospitalization and associated morbidity (e.g., infection, deep venous thrombosis). Continuous EEG monitoring is mandatory. Hypotension is most common with pentobarbital, which may accumulate in tissues and require many days for clearance. Midazolam is less morbid but often leads to tolerance and tachyphylaxis."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"1f54fd",
"children":[
"In patients with likely convulsive status epilepticus (CSE), empiric therapy is indicated without awaiting results of electroencephalography, imaging, serum studies, or lumbar puncture because a longer duration of CSE is strongly linked to worse outcomes."
]
},
{
"type":"keypoint",
"hlId":"be68c0",
"children":[
"First-line treatment of convulsive status epilepticus is an intravenous benzodiazepine typically followed by an intravenous antiepileptic drug to avoid seizure recurrence."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s3_7_2",
"title":{
"__html":"Nonconvulsive Status Epilepticus"
},
"titleNode":{
"type":"section-title",
"hlId":"62e5d1",
"children":[
"Nonconvulsive Status Epilepticus"
]
},
"children":[
{
"type":"p",
"hlId":"ac3883",
"children":[
"NCSE refers to episodes of electrical seizure activity without clinically evident seizure activity. It should be suspected when a patient has altered mental status of unknown cause. NCSE is common in medical, surgical, and neurologic intensive care units and should be considered even when a patient has no known neurologic history. NCSE typically occurs in 15% to 25% of critically ill patients with encephalopathy. Certain situations should prompt immediate continuous EEG monitoring (see ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t18",
"wrapId":"20",
"children":[
"Table 18"
]
}
]
},
")"
]
},
", which is required for diagnosis. Shorter duration EEG is typically inadequate because many patients experience intermittent rather than continuous seizures. At least 24 hours of monitoring is recommended in noncomatose patients, and at least 48 hours is recommended in comatose patients."
]
},
{
"type":"inline-wrap",
"wrapId":"20",
"contentIds":[
"mk19_a_nr_t18"
]
},
{
"type":"p",
"hlId":"cb5122",
"children":[
"NCSE that does not occur directly after GTCS or CSE may not carry as high a risk to the patient, and thus treatment is not necessarily as aggressive as that for CSE. Treatment is based on clinical examination and not on EEG alone. If the patient is not comatose, initiating aggressive therapy with intubation and an IV anesthetic–induced coma is usually avoided because risks may outweigh benefits. Outcomes are typically related to seizure cause rather than severity of seizures or altered mentation."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"e89b03",
"children":[
"Nonconvulsive status epilepticus should be suspected and continuous electroencephalographic monitoring initiated when a patient has altered mental status with an unclear cause, including patients in medical or surgical ICUs, even those without known neurologic history."
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s3_8",
"bibliography":true,
"title":{
"__html":"Bibliography"
},
"titleNode":{
"type":"section-title",
"hlId":"a7cc81",
"children":[
"Bibliography"
]
},
"children":[
{
"type":"references",
"children":[
{
"type":"reference",
"children":[
"Glauser T, Shinnar S, Gloss D, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: Report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr. 2016;16:48-61. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/26900382",
"target":"_blank"
},
"children":[
"PMID: 26900382"
]
},
" doi:10.5698/1535-7597-16.1.48."
]
},
{
"type":"reference",
"children":[
"Gloss D, Pargeon K, Pack A, et al; AAN Guideline Subcommittee. Antiseizure medication withdrawal in seizure-free patients: practice advisory update summary: report of the AAN Guideline Subcommittee. Neurology. 2021;97:1072-1081. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/34873018",
"target":"_blank"
},
"children":[
"PMID: 34873018"
]
},
" doi:10.1212/WNL.0000000000012944"
]
},
{
"type":"reference",
"children":[
"Gynecologic management of adolescents and young women with seizure disorders: ACOG committee opinion, number 806. Obstet Gynecol. 2020;135:e213-20. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/32332416",
"target":"_blank"
},
"children":[
"PMID: 32332416"
]
}
]
},
{
"type":"reference",
"children":[
"Herman ST, Abend NS, Bleck TP, et al; Critical Care Continuous EEG Task Force of the American Clinical Neurophysiology Society. Consensus statement on continuous EEG in critically ill adults and children, part I: indications. J Clin Neurophysiol. 2015;32:87-95. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/25626778",
"target":"_blank"
},
"children":[
"PMID: 25626778"
]
}
]
},
{
"type":"reference",
"children":[
"Kanner AM, Ashman E, Gloss D, et al. Practice guideline update summary: efficacy and tolerability of the new antiepileptic drugs I: treatment of new-onset epilepsy: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2018;91:74-81. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/29898971",
"target":"_blank"
},
"children":[
"PMID: 29898971"
]
}
]
},
{
"type":"reference",
"children":[
"Kapur J, Elm J, Chamberlain JM, et al; NETT and PECARN Investigators. Randomized trial of three anticonvulsant medications for status epilepticus. N Engl J Med. 2019;381:2103-13. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/31774955",
"target":"_blank"
},
"children":[
"PMID: 31774955"
]
}
]
},
{
"type":"reference",
"children":[
"Krumholz A, Wiebe S, Gronseth GS, et al. Evidence-based guideline: Management of an unprovoked first seizure in adults: report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2015;84:1705-13. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/25901057",
"target":"_blank"
},
"children":[
"PMID: 25901057"
]
}
]
},
{
"type":"reference",
"children":[
"Pack AM. Epilepsy Overview and revised classification of seizures and epilepsies. Continuum (Minneap Minn). 2019;25:306-21. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30921011",
"target":"_blank"
},
"children":[
"PMID: 30921011"
]
}
]
},
{
"type":"reference",
"children":[
"Sazgar M. Treatment of women with epilepsy. Continuum (Minneap Minn). 2019 Apr;25(2):408-30. doi:10.1212/CON.0000000000000713. Review. PubMed PMID: 30921016."
]
}
]
}
]
}
]
},
"tablesContent":{
"mk19_a_nr_t14":{
"id":"mk19_a_nr_t14",
"number":14,
"bookId":"nr",
"title":{
"__html":"Examples of Focal Aware Seizures<sup>a</sup>"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"376136",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 14. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_nr_t14"
}
]
},
"Examples of Focal Aware Seizures",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"00699b",
"class":"col hd l",
"children":[
"Lobe"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6f071b",
"class":"col hd l",
"children":[
"Clinical Presentation"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6aa29d",
"class":"cell txt l",
"children":[
"Frontal"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"059a0e",
"class":"cell txt l",
"children":[
"Focal contralateral motor activity (clonic jerking)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"19e45f",
"class":"cell txt l",
"children":[
"Temporal"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0fe534",
"class":"cell txt l",
"children":[
"Epigastric rising sensation (nausea, butterflies); aphasia; déjà vu; fear; elation; auditory, olfactory,",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
},
" and gustatory",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
},
" sensations"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"07e23b",
"class":"cell txt l",
"children":[
"Parietal"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f5b355",
"class":"cell txt l",
"children":[
"Focal contralateral pain, numbness, or paresthesias"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bb8b8a",
"class":"cell txt l",
"children":[
"Occipital"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c24143",
"class":"cell txt l",
"children":[
"Contralateral homonymous visual loss or nonformed hallucinations (dots, lines, flashes of light)"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"Also known as simple partial seizures (which include auras)."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
},
"Altered smell and taste also can be seen in psychogenic nonepileptic events."
]
]
},
"mk19_a_nr_t15":{
"id":"mk19_a_nr_t15",
"number":15,
"bookId":"nr",
"title":{
"__html":"Clinical Differentiation of Seizure Types Presenting As Staring Episodes"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"82a9fb",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 15. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_nr_t15"
}
]
},
"Clinical Differentiation of Seizure Types Presenting As Staring Episodes"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"63716a",
"class":"col hd l",
"children":[
"Seizure Feature"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7d91e4",
"class":"col hd l",
"children":[
"Absence Seizure"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"16121a",
"class":"col hd l",
"children":[
"Focal Impaired Awareness Seizure",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6ed3cf",
"class":"cell txt l",
"children":[
"Aura"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bafd73",
"class":"cell txt l",
"children":[
"No"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7ed6c3",
"class":"cell txt l",
"children":[
"Possible"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"598f11",
"class":"cell txt l",
"children":[
"Onset"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0d3464",
"class":"cell txt l",
"children":[
"Abrupt"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"768ccb",
"class":"cell txt l",
"children":[
"Gradual or abrupt"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e02d2a",
"class":"cell txt l",
"children":[
"Duration"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6dd149",
"class":"cell txt l",
"children":[
"<15 s"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"75de9c",
"class":"cell txt l",
"children":[
">30 s"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"61e773",
"class":"cell txt l",
"children":[
"Termination"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0d3464",
"class":"cell txt l",
"children":[
"Abrupt"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b2804e",
"class":"cell txt l",
"children":[
"Usually gradual"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d75c32",
"class":"cell txt l",
"children":[
"Postictal state"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"960b44",
"class":"cell txt l",
"children":[
"Normal"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"391edf",
"class":"cell txt l",
"children":[
"Lethargy, confusion"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7cf395",
"class":"cell txt l",
"children":[
"Frequency"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"807c3d",
"class":"cell txt l",
"children":[
"Multiple daily"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8fdcf6",
"class":"cell txt l",
"children":[
"Once weekly or monthly"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b27eaa",
"class":"cell txt l",
"children":[
"Precipitated by hyperventilation"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"94eeb9",
"class":"cell txt l",
"children":[
"Usually"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"389344",
"class":"cell txt l",
"children":[
"Unlikely"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1e7d9d",
"class":"cell txt l",
"children":[
"Associated seizure types"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3a47ca",
"class":"cell txt l",
"children":[
"Generalized onset seizures (myoclonic, primarily generalized tonic-clonic, tonic, atonic)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"416c8a",
"class":"cell txt l",
"children":[
"Focal onset seizures (simple partial or secondarily generalized tonic-clonic)"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"Also known as a complex partial or focal dyscognitive seizure."
]
]
},
"mk19_a_nr_t16":{
"id":"mk19_a_nr_t16",
"number":16,
"bookId":"nr",
"title":{
"__html":"Clinical Differentiation of Generalized Tonic-Clonic Seizures and Syncope"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"8adf99",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 16. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_nr_t16"
}
]
},
"Clinical Differentiation of Generalized Tonic-Clonic Seizures and Syncope"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"63716a",
"class":"col hd l",
"children":[
"Seizure Feature"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0f8802",
"class":"col hd l",
"children":[
"Generalized Tonic-Clonic Seizures"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"14359d",
"class":"col hd l",
"children":[
"Syncope"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cef0e9",
"class":"cell txt l",
"children":[
"Warning symptoms"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0b8e44",
"class":"cell txt l",
"children":[
"Possible epileptic aura immediately before onset"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"83b8a0",
"class":"cell txt l",
"children":[
"Prodrome of lightheadedness, nausea, warmth, diaphoresis, blurred or tunnel vision, generalized weakness, palpitations, and a “faint” feeling"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"600827",
"class":"cell txt l",
"children":[
"Self-protection"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6c1fc3",
"class":"cell txt l",
"children":[
"Aura may or may not be long enough to ensure patient safety, but seizure is not preventable"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a2f977",
"class":"cell txt l",
"children":[
"Lying or sitting down may prevent progression to LOC"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a597af",
"class":"cell txt l",
"children":[
"Muscle tone"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2b2b0b",
"class":"cell txt l",
"children":[
"Generalized stiffening"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"de9e20",
"class":"cell txt l",
"children":[
"Generalized loss of tone"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"89979e",
"class":"cell txt l",
"children":[
"Motor activity"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e73789",
"class":"cell txt l",
"children":[
"Generalized clonic shaking (rhythmic, synchronous whole-body jerks)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a181c0",
"class":"cell txt l",
"children":[
"Generalized myoclonic shaking (whole-body shaking or isolated subtle twitching of limbs)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cb5feb",
"class":"cell txt l",
"children":[
"Color"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2d4485",
"class":"cell txt l",
"children":[
"May have cyanosis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"249129",
"class":"cell txt l",
"children":[
"May have pallor"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d4beff",
"class":"cell txt l",
"children":[
"Duration of LOC"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5547a4",
"class":"cell txt l",
"children":[
"Usually >1 minute"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"02d47a",
"class":"cell txt l",
"children":[
"Usually <1 minute"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d75c32",
"class":"cell txt l",
"children":[
"Postictal state"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f52a1e",
"class":"cell txt l",
"children":[
"Confusion, lethargy, combativeness, somnolence"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"629ee6",
"class":"cell txt l",
"children":[
"Normal, other than a situationally appropriate memory loss of event"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"LOC = loss of consciousness."
]
]
},
"mk19_a_nr_t17":{
"id":"mk19_a_nr_t17",
"number":17,
"bookId":"nr",
"title":{
"__html":"Clinical Differentiation of GTCS and PNES"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"740a28",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 17. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_nr_t17"
}
]
},
"Clinical Differentiation of GTCS and PNES"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"63716a",
"class":"col hd l",
"children":[
"Seizure Feature"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"06375d",
"class":"col hd l",
"children":[
"GTCS"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f6d226",
"class":"col hd l",
"children":[
"PNES"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"43c4e4",
"class":"cell txt l",
"children":[
"Stereotyped"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"93cba0",
"class":"cell txt l",
"children":[
"Yes"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e904c7",
"class":"cell txt l",
"children":[
"No (varies from event to event)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"85e97a",
"class":"cell txt l",
"children":[
"Eyelids"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c3bf44",
"class":"cell txt l",
"children":[
"Open"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1dde37",
"class":"cell txt l",
"children":[
"Closed (may resist opening)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cb5feb",
"class":"cell txt l",
"children":[
"Color"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2d4485",
"class":"cell txt l",
"children":[
"May have cyanosis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"273d69",
"class":"cell txt l",
"children":[
"May turn red"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a3fe85",
"class":"cell txt l",
"children":[
"Vocalization"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e4a10a",
"class":"cell txt l",
"children":[
"Ictal cry (sharp, loud, deep single inspiration against contracted epiglottis)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2d1c88",
"class":"cell txt l",
"children":[
"Intermittent breath holding alternating with gasping/rapid breaths, or crying/sobbing"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a597af",
"class":"cell txt l",
"children":[
"Muscle tone"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ee64df",
"class":"cell txt l",
"children":[
"Starts with stiffening of all limbs (tonic)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"dd6ab3",
"class":"cell txt l",
"children":[
"Patients usually limp or limber; may resist movement or make atypical postures (fists, claws)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"89979e",
"class":"cell txt l",
"children":[
"Motor activity"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3e81a0",
"class":"cell txt l",
"children":[
"Synchronous shaking of all limbs (clonic)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9dc570",
"class":"cell txt l",
"children":[
"Asynchronous flailing of variable limbs, side-to-side head shaking, pelvic thrusting",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2faccc",
"class":"cell txt l",
"children":[
"Motor pattern"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c13fa7",
"class":"cell txt l",
"children":[
"Shaking starts at high frequency and gradually slows down"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a5aa8a",
"class":"cell txt l",
"children":[
"Shaking may speed up or vary in frequency"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e02d2a",
"class":"cell txt l",
"children":[
"Duration"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6f39c4",
"class":"cell txt l",
"children":[
"Usually ends within <5 min"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fd56f5",
"class":"cell txt l",
"children":[
"Prolonged, or waxes and wanes over >5 min or even hours"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-9 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d78f5a",
"class":"cell txt l",
"children":[
"Consciousness/memory"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a6fd9e",
"class":"cell txt l",
"children":[
"Impaired/lost"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"86ae26",
"class":"cell txt l",
"children":[
"May be retained (may hear or remember but not respond)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-10 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d75c32",
"class":"cell txt l",
"children":[
"Postictal state"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6d8118",
"class":"cell txt l",
"children":[
"Confused, lethargic"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bb1c4f",
"class":"cell txt l",
"children":[
"May have relatively normal mental status despite high frequency of “seizures”"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-11 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"15eff9",
"class":"cell txt l",
"children":[
"Postictal breathing"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cc9939",
"class":"cell txt l",
"children":[
"Slow, deep, loud, snoring-like stertor"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"aabbf8",
"class":"cell txt l",
"children":[
"Normal or rapid panting"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"GTCS = generalized tonic-clonic seizure; PNES = psychogenic nonepileptic spell/event."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"These typically psychogenic symptoms may be seen in true epileptic frontal lobe seizures."
]
]
},
"mk19_a_nr_t18":{
"id":"mk19_a_nr_t18",
"number":18,
"bookId":"nr",
"title":{
"__html":"Indications for Immediate Continuous Video Electroencephalographic Monitoring in the Critical Care Setting"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"6f2268",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 18. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_nr_t18"
}
]
},
"Indications for Immediate Continuous Video Electroencephalographic Monitoring in the Critical Care Setting"
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3b6107",
"class":"cell txt l",
"children":[
"AMS following CSE",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
" or clinical seizures"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2ecc69",
"class":"cell txt l",
"children":[
"AMS with acute brain injury (such as hemorrhage, trauma, infection, stroke, hypoxia, cardiac arrest)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e8463c",
"class":"cell txt l",
"children":[
"Unexplained AMS with subacute or chronic brain injury (tumor, history of epilepsy)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e40ddf",
"class":"cell txt l",
"children":[
"Unexplained AMS (or mental fluctuation) without acute brain injury (as in sepsis)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"308964",
"class":"cell txt l",
"children":[
"Unexplained AMS following a CNS procedure or CNS instrumentation"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a2d3cc",
"class":"cell txt l",
"children":[
"Deep sedation and paralysis that limit the ability to perform a neurologic examination (as is used with therapeutic hypothermia, ECMO)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8d2948",
"class":"cell txt l",
"children":[
"Clinical episodes concerning for seizures (such as unexplained muscle or eye movements)",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"AMS = altered mental status; CNS = central nervous system; CSE = convulsive status epilepticus; ECMO = extracorporeal membrane oxygenation; EEG = electroencephalography."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"If CSE is suspected, treatment should begin before EEG is performed or results are available; if nonconvulsive status epilepticus is suspected, treatment most often should await EEG results."
]
]
},
"mk19_a_nr_t19":{
"id":"mk19_a_nr_t19",
"number":19,
"bookId":"nr",
"title":{
"__html":"Potential Causes of Seizures or Epilepsy"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"70c56c",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 19. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_nr_t19"
}
]
},
"Potential Causes of Seizures or Epilepsy"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"684620",
"class":"col hd l",
"children":[
"Seizure-Provoking Factors"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4ab262",
"class":"col hd l",
"children":[
"Epilepsy Risk Factors"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7626f4",
"class":"col hd l",
"children":[
"Seizure Triggers"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0a8d38",
"class":"cell txt l",
"children":[
"Hypo- or hypernatremia"
]
},
" ",
{
"type":"p",
"hlId":"0151c8",
"class":"cell txt l",
"children":[
"Hypo- or hypercalcemia"
]
},
" ",
{
"type":"p",
"hlId":"2a42b1",
"class":"cell txt l",
"children":[
"Hypomagnesemia"
]
},
" ",
{
"type":"p",
"hlId":"f8f006",
"class":"cell txt l",
"children":[
"Hypoglycemia"
]
},
" ",
{
"type":"p",
"hlId":"c97984",
"class":"cell txt l",
"children":[
"Hyperammonemia or hepatic failure"
]
},
" ",
{
"type":"p",
"hlId":"00dd46",
"class":"cell txt l",
"children":[
"Uremia or kidney failure"
]
},
" ",
{
"type":"p",
"hlId":"4f3896",
"class":"cell txt l",
"children":[
"Acute head trauma, meningitis, encephalitis, stroke, or hypoxia/ischemia"
]
},
" ",
{
"type":"p",
"hlId":"dce67f",
"class":"cell txt l",
"children":[
"Alcohol intoxication or withdrawal"
]
},
" ",
{
"type":"p",
"hlId":"48ee1f",
"class":"cell txt l",
"children":[
"Recreational drug use"
]
},
" ",
{
"type":"p",
"hlId":"0b614f",
"class":"cell txt l",
"children":[
"Benzodiazepine withdrawal"
]
},
" ",
{
"type":"p",
"hlId":"ebad16",
"class":"cell txt l",
"children":[
"Baclofen withdrawal"
]
},
" ",
{
"type":"p",
"hlId":"a28b9e",
"class":"cell txt l",
"children":[
"Fluoroquinolones"
]
},
" ",
{
"type":"p",
"hlId":"905b4e",
"class":"cell txt l",
"children":[
"Carbapenems"
]
},
" ",
{
"type":"p",
"hlId":"deaa4d",
"class":"cell txt l",
"children":[
"Cefepime"
]
},
" ",
{
"type":"p",
"hlId":"a99c58",
"class":"cell txt l",
"children":[
"Metronidazole"
]
},
" ",
{
"type":"p",
"hlId":"85e01b",
"class":"cell txt l",
"children":[
"Tramadol"
]
},
" ",
{
"type":"p",
"hlId":"9f27a7",
"class":"cell txt l",
"children":[
"Meperidine"
]
},
" ",
{
"type":"p",
"hlId":"4b29b1",
"class":"cell txt l",
"children":[
"Morphine"
]
},
" ",
{
"type":"p",
"hlId":"4024de",
"class":"cell txt l",
"children":[
"Bupropion"
]
},
" ",
{
"type":"p",
"hlId":"dc7602",
"class":"cell txt l",
"children":[
"Clozapine",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" ",
{
"type":"p",
"hlId":"5c29ee",
"class":"cell txt l",
"children":[
"Lithium",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" ",
{
"type":"p",
"hlId":"6693b2",
"class":"cell txt l",
"children":[
"Tricyclic antidepressants",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" ",
{
"type":"p",
"hlId":"cf6d47",
"class":"cell txt l",
"children":[
"Typical antipsychotic agents",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"819e4b",
"class":"cell txt l",
"children":[
"Febrile seizures"
]
},
" ",
{
"type":"p",
"hlId":"642eee",
"class":"cell txt l",
"children":[
"Family history (especially first-degree relatives)"
]
},
" ",
{
"type":"p",
"hlId":"47322b",
"class":"cell txt l",
"children":[
"Past meningitis/encephalitis"
]
},
" ",
{
"type":"p",
"hlId":"6b23f7",
"class":"cell txt l",
"children":[
"History of structural brain lesion (such as stroke, tumor)"
]
},
" ",
{
"type":"p",
"hlId":"a816e8",
"class":"cell txt l",
"children":[
"Past significant head trauma (loss of consciousness or amnesia >30 min, penetrating skull injury)"
]
},
" ",
{
"type":"p",
"hlId":"0d4fad",
"class":"cell txt l",
"children":[
"Preterm birth"
]
},
" ",
{
"type":"p",
"hlId":"47a725",
"class":"cell txt l",
"children":[
"Birth injury, asphyxia, or stroke"
]
},
" ",
{
"type":"p",
"hlId":"6eb538",
"class":"cell txt l",
"children":[
"Neurologic developmental delay"
]
},
" ",
{
"type":"p",
"hlId":"c8e450",
"class":"cell txt l",
"children":[
"Intellectual disability"
]
},
" ",
{
"type":"p",
"hlId":"00edf8",
"class":"cell txt l",
"children":[
"History of brain surgery"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"67f108",
"class":"cell txt l",
"children":[
"Sleep deprivation",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
}
]
},
" ",
{
"type":"p",
"hlId":"5780df",
"class":"cell txt l",
"children":[
"Fever"
]
},
" ",
{
"type":"p",
"hlId":"703076",
"class":"cell txt l",
"children":[
"Emotional stress"
]
},
" ",
{
"type":"p",
"hlId":"677f7d",
"class":"cell txt l",
"children":[
"Acute infection (nonneurologic)"
]
},
" ",
{
"type":"p",
"hlId":"582abf",
"class":"cell txt l",
"children":[
"Hyperventilation"
]
},
" ",
{
"type":"p",
"hlId":"a14cbb",
"class":"cell txt l",
"children":[
"Photic stimulation"
]
},
" ",
{
"type":"p",
"hlId":"83f571",
"class":"cell txt l",
"children":[
"Music, reading, eating (only in specific reflex epilepsies)"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"Can be used in patients with epilepsy, if needed."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
},
"Typically does not trigger seizures in patients without epilepsy and is not considered a provoking factor."
]
]
},
"mk19_a_nr_t20":{
"id":"mk19_a_nr_t20",
"number":20,
"bookId":"nr",
"title":{
"__html":"Spectrum of Use of Antiepileptic Drugs"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"f9d975",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 20. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_nr_t20"
}
]
},
"Spectrum of Use of Antiepileptic Drugs"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"13e038",
"class":"col hd l",
"children":[
"Population"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2e27d2",
"class":"col hd l",
"children":[
"First-Line Agent"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8cceae",
"class":"col hd l",
"children":[
"Second-Line Agent"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ea61e2",
"class":"col hd l",
"children":[
"Considerations"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2f0d18",
"class":"cell txt l",
"children":[
"Patients with focal seizures"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"aeb6f9",
"class":"cell txt l",
"children":[
"Lamotrigine"
]
},
" ",
{
"type":"p",
"hlId":"892a6b",
"class":"cell txt l",
"children":[
"Levetiracetam"
]
},
" ",
{
"type":"p",
"hlId":"5351f1",
"class":"cell txt l",
"children":[
"Oxcarbazepine"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"051b8d",
"class":"cell txt l",
"children":[
"Carbamazepine"
]
},
" ",
{
"type":"p",
"hlId":"3b68f2",
"class":"cell txt l",
"children":[
"Gabapentin"
]
},
" ",
{
"type":"p",
"hlId":"c5feee",
"class":"cell txt l",
"children":[
"Pregabalin"
]
},
" ",
{
"type":"p",
"hlId":"f00489",
"class":"cell txt l",
"children":[
"Topiramate"
]
},
" ",
{
"type":"p",
"hlId":"64b5fa",
"class":"cell txt l",
"children":[
"Zonisamide"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"43f2ec",
"class":"cell txt l",
"children":[
"Includes treatment of secondarily generalized tonic-clonic seizures (i.e., focal evolving to bilateral tonic-clonic)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7a0246",
"class":"cell txt l",
"children":[
"Patients with generalized seizures"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"39bfe8",
"class":"cell txt l",
"children":[
"Ethosuximide (absence only)"
]
},
" ",
{
"type":"p",
"hlId":"c53d54",
"class":"cell txt l",
"children":[
"Lamotrigine (may worsen myoclonic seizures)"
]
},
" ",
{
"type":"p",
"hlId":"892a6b",
"class":"cell txt l",
"children":[
"Levetiracetam"
]
},
" ",
{
"type":"p",
"hlId":"5aba32",
"class":"cell txt l",
"children":[
"Valproate"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f00489",
"class":"cell txt l",
"children":[
"Topiramate"
]
},
" ",
{
"type":"p",
"hlId":"64b5fa",
"class":"cell txt l",
"children":[
"Zonisamide"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b328e8",
"class":"cell txt l",
"children":[
"May be worsened by gabapentin, pregabalin, carbamazepine, and oxcarbazepine"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b1ecbc",
"class":"cell txt l",
"children":[
"Women of childbearing potential"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"aeb6f9",
"class":"cell txt l",
"children":[
"Lamotrigine"
]
},
" ",
{
"type":"p",
"hlId":"892a6b",
"class":"cell txt l",
"children":[
"Levetiracetam"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5351f1",
"class":"cell txt l",
"children":[
"Oxcarbazepine"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4d48f4",
"class":"cell txt l",
"children":[
"Avoid carbamazepine, phenobarbital, phenytoin, topiramate, and valproate"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"dd2ff2",
"class":"cell txt l",
"children":[
"Older patients"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3b68f2",
"class":"cell txt l",
"children":[
"Gabapentin"
]
},
" ",
{
"type":"p",
"hlId":"aeb6f9",
"class":"cell txt l",
"children":[
"Lamotrigine"
]
},
" ",
{
"type":"p",
"hlId":"892a6b",
"class":"cell txt l",
"children":[
"Levetiracetam"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f31296",
"class":"cell txt l",
"children":[
"Higher risk for hyponatremia with carbamazepine, oxcarbazepine, and eslicarbazepine, especially with concomitant diuretics"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
},
"mk19_a_nr_t21":{
"id":"mk19_a_nr_t21",
"number":21,
"bookId":"nr",
"title":{
"__html":"Adverse Effects of Selected Antiepileptic Drugs and Recommended Laboratory Monitoring"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"0cbfc6",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 21. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_nr_t21"
}
]
},
"Adverse Effects of Selected Antiepileptic Drugs and Recommended Laboratory Monitoring"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5db77f",
"class":"col hd l",
"children":[
"Drug"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3251b0",
"class":"col hd l",
"children":[
"Common Adverse Effects"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6d4ad7",
"class":"col hd l",
"children":[
"Serious Adverse Effects"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"91e9ce",
"class":"col hd l",
"children":[
"Recommended Laboratory Monitoring"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"85b0f7",
"class":"cell txt l",
"children":[
"Carbamazepine, oxcarbazepine, and eslicarbazepine"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a97305",
"class":"cell txt l",
"children":[
"Sedation, nausea, ataxia, tremor, diplopia, imbalance, headache, and dose-dependent dizziness"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6ab8c0",
"class":"cell txt l",
"children":[
"Hyponatremia, rash, pancytopenia, osteoporosis, hepatotoxicity"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"535d9f",
"class":"cell txt l",
"children":[
"CBC, liver chemistry studies, bone density, serum drug level"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c90a25",
"class":"cell txt l",
"children":[
"Felbamate"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c4c43b",
"class":"cell txt l",
"children":[
"Insomnia, weight loss, nausea, vomiting, and diarrhea"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1df10b",
"class":"cell txt l",
"children":[
"Aplastic anemia and hepatotoxicity",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"68d312",
"class":"cell txt l",
"children":[
"CBC, liver chemistry studies"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"364a98",
"class":"cell txt l",
"children":[
"Gabapentin and pregabalin"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0b30e6",
"class":"cell txt l",
"children":[
"Sedation, weight gain, edema, and dose-dependent dizziness"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"26aeab",
"class":"cell txt l",
"children":[
"—"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"26aeab",
"class":"cell txt l",
"children":[
"—"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7fdc88",
"class":"cell txt l",
"children":[
"Lacosamide"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3e823c",
"class":"cell txt l",
"children":[
"Sedation, nausea, ataxia, tremor, diplopia, imbalance, headache, dose-dependent dizziness, and PR-interval prolongation"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"af6165",
"class":"cell txt l",
"children":[
"Atrioventricular block, atrial fibrillation"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0cb215",
"class":"cell txt l",
"children":[
"ECG"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"aeb6f9",
"class":"cell txt l",
"children":[
"Lamotrigine"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0f183a",
"class":"cell txt l",
"children":[
"Sedation, nausea, ataxia, tremor, diplopia, imbalance, headache, insomnia, and dose-dependent dizziness"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e6ce50",
"class":"cell txt l",
"children":[
"Rash"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b655db",
"class":"cell txt l",
"children":[
"Serum drug level"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b17d3d",
"class":"cell txt l",
"children":[
"Levetiracetam and brivaracetam"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d8c5d2",
"class":"cell txt l",
"children":[
"Sedation, irritability, psychosis, and depression"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f5b204",
"class":"cell txt l",
"children":[
"Suicidal ideation",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
},
" and thrombocytopenia (rare)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"26aeab",
"class":"cell txt l",
"children":[
"—"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9a835f",
"class":"cell txt l",
"children":[
"Perampanel"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"69b5b1",
"class":"cell txt l",
"children":[
"Dizziness, headache, and sedation"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7ebf36",
"class":"cell txt l",
"children":[
"Homicidal ideation"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"26aeab",
"class":"cell txt l",
"children":[
"—"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4f0812",
"class":"cell txt l",
"children":[
"Phenobarbital"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b0f1a1",
"class":"cell txt l",
"children":[
"Sedation (but paradoxical hyperactivity in children)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6c7bc8",
"class":"cell txt l",
"children":[
"Rash, pancytopenia, osteoporosis, hepatotoxicity"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"535d9f",
"class":"cell txt l",
"children":[
"CBC, liver chemistry studies, bone density, serum drug level"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-9 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"221fb3",
"class":"cell txt l",
"children":[
"Phenytoin"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"290a2a",
"class":"cell txt l",
"children":[
"Sedation, nausea, ataxia, tremor, diplopia, imbalance, headache, and dose-dependent dizziness; if given IV, tissue necrosis (with extravasation), bradycardia, hypotension, and asystole"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"60e0ac",
"class":"cell txt l",
"children":[
"Rash, gingival hyperplasia, cerebellar atrophy, peripheral neuropathy, pancytopenia, osteoporosis, hepatotoxicity"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"535d9f",
"class":"cell txt l",
"children":[
"CBC, liver chemistry studies, bone density, serum drug level"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-10 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8a0fba",
"class":"cell txt l",
"children":[
"Tiagabine"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a97305",
"class":"cell txt l",
"children":[
"Sedation, nausea, ataxia, tremor, diplopia, imbalance, headache, and dose-dependent dizziness"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1b1008",
"class":"cell txt l",
"children":[
"Acute confusion and encephalopathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8a0fba",
"class":"cell txt l",
"children":[
"Tiagabine"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-11 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fb51a7",
"class":"cell txt l",
"children":[
"Topiramate and zonisamide"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"193233",
"class":"cell txt l",
"children":[
"Sedation, nausea, ataxia, tremor, diplopia, imbalance, headache, word finding difficulty, poor concentration, paresthesias, weight loss, anhidrosis, and dose-dependent dizziness"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"dfb996",
"class":"cell txt l",
"children":[
"Nephrolithiasis, acute angle glaucoma, psychosis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d53ff4",
"class":"cell txt l",
"children":[
"BMP in select cases"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-12 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"83bef1",
"class":"cell txt l",
"children":[
"Valproic acid"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4deba7",
"class":"cell txt l",
"children":[
"Sedation, nausea, ataxia, tremor, diplopia, imbalance, headache, and dose-dependent dizziness; weight gain, hair loss, PCOS, and reversible parkinsonism with dementia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"640cac",
"class":"cell txt l",
"children":[
"Pancytopenia, osteoporosis, hepatotoxicity, pancreatitis, hyperammonemia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"564c23",
"class":"cell txt l",
"children":[
"CBC, liver chemistry studies, bone density, serum drug level, serum ammonia level in select cases"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"BMP = basic metabolic profile; CBC = complete blood count; IV, intravenously; PCOS = polycystic ovary syndrome."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"A serious and potentially fatal adverse effect that limits this drug's use (and requires close monitoring)."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
},
"A concern with all antiepileptic drugs, but especially levetiracetam."
]
]
},
"mk19_a_nr_t22":{
"id":"mk19_a_nr_t22",
"number":22,
"bookId":"nr",
"title":{
"__html":"Key Pharmacologic Issues with Selected Antiepileptic Drugs"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"0c8c26",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 22. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_nr_t22"
}
]
},
"Key Pharmacologic Issues with Selected Antiepileptic Drugs"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a3ef6c",
"class":"col hd l",
"children":[
"Inducers of Hepatic Enzymes",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a,b"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0dbb80",
"class":"col hd l",
"children":[
"Inhibitors of Hepatic Enzymes",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ae0f31",
"class":"col hd l",
"children":[
"Requires Dose Adjustment in Kidney Dysfunction"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"79a03c",
"class":"col hd l",
"children":[
"Avoid in Hepatic Dysfunction"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9e7a48",
"class":"col hd l",
"children":[
"Highly Albumin Bound",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"c"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"457eb4",
"class":"col hd l",
"children":[
"No Significant Drug-Drug Interactions"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"051b8d",
"class":"cell txt l",
"children":[
"Carbamazepine"
]
},
" ",
{
"type":"p",
"hlId":"5351f1",
"class":"cell txt l",
"children":[
"Oxcarbazepine"
]
},
" ",
{
"type":"p",
"hlId":"4f0812",
"class":"cell txt l",
"children":[
"Phenobarbital"
]
},
" ",
{
"type":"p",
"hlId":"221fb3",
"class":"cell txt l",
"children":[
"Phenytoin"
]
},
" ",
{
"type":"p",
"hlId":"f00489",
"class":"cell txt l",
"children":[
"Topiramate"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d6be04",
"class":"cell txt l",
"children":[
"Valproic acid",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"d"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3b68f2",
"class":"cell txt l",
"children":[
"Gabapentin"
]
},
" ",
{
"type":"p",
"hlId":"892a6b",
"class":"cell txt l",
"children":[
"Levetiracetam"
]
},
" ",
{
"type":"p",
"hlId":"c5feee",
"class":"cell txt l",
"children":[
"Pregabalin"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"051b8d",
"class":"cell txt l",
"children":[
"Carbamazepine"
]
},
" ",
{
"type":"p",
"hlId":"4f0812",
"class":"cell txt l",
"children":[
"Phenobarbital"
]
},
" ",
{
"type":"p",
"hlId":"221fb3",
"class":"cell txt l",
"children":[
"Phenytoin"
]
},
" ",
{
"type":"p",
"hlId":"83bef1",
"class":"cell txt l",
"children":[
"Valproic acid"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"221fb3",
"class":"cell txt l",
"children":[
"Phenytoin"
]
},
" ",
{
"type":"p",
"hlId":"5aba32",
"class":"cell txt l",
"children":[
"Valproate"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3b68f2",
"class":"cell txt l",
"children":[
"Gabapentin"
]
},
" ",
{
"type":"p",
"hlId":"7fdc88",
"class":"cell txt l",
"children":[
"Lacosamide"
]
},
" ",
{
"type":"p",
"hlId":"892a6b",
"class":"cell txt l",
"children":[
"Levetiracetam"
]
},
" ",
{
"type":"p",
"hlId":"c5feee",
"class":"cell txt l",
"children":[
"Pregabalin"
]
},
" ",
{
"type":"p",
"hlId":"64b5fa",
"class":"cell txt l",
"children":[
"Zonisamide"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"May cause osteoporosis and interact with lamotrigine."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
},
"May decrease statin and oral contraceptive efficacy."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"c"
]
},
"Warrants checking unbound (free) blood level, especially in kidney failure and hypoalbuminemia."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"d"
]
},
"May accelerate bone catabolism and lead to osteoporosis."
]
]
}
}
}